The Market Reports

Index

1 Pet Meds and Supplements Market Overview
1.1 Product Overview and Scope of Pet Meds and Supplements
1.2 Pet Meds and Supplements Segment by Type
1.2.1 Global Pet Meds and Supplements Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 External Use
1.2.3 Oral Use
1.3 Pet Meds and Supplements Segment by Application
1.3.1 Global Pet Meds and Supplements Sales Comparison by Application: (2022-2028)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Rabbit
1.3.5 Bird
1.3.6 Other
1.4 Global Pet Meds and Supplements Market Size Estimates and Forecasts
1.4.1 Global Pet Meds and Supplements Revenue 2017-2028
1.4.2 Global Pet Meds and Supplements Sales 2017-2028
1.4.3 Pet Meds and Supplements Market Size by Region: 2017 Versus 2021 Versus 2028
2 Pet Meds and Supplements Market Competition by Manufacturers
2.1 Global Pet Meds and Supplements Sales Market Share by Manufacturers (2017-2022)
2.2 Global Pet Meds and Supplements Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Pet Meds and Supplements Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Pet Meds and Supplements Manufacturing Sites, Area Served, Product Type
2.5 Pet Meds and Supplements Market Competitive Situation and Trends
2.5.1 Pet Meds and Supplements Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pet Meds and Supplements Players Market Share by Revenue
2.5.3 Global Pet Meds and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Meds and Supplements Retrospective Market Scenario by Region
3.1 Global Pet Meds and Supplements Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Pet Meds and Supplements Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Pet Meds and Supplements Market Facts & Figures by Country
3.3.1 North America Pet Meds and Supplements Sales by Country
3.3.2 North America Pet Meds and Supplements Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Pet Meds and Supplements Market Facts & Figures by Country
3.4.1 Europe Pet Meds and Supplements Sales by Country
3.4.2 Europe Pet Meds and Supplements Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pet Meds and Supplements Market Facts & Figures by Region
3.5.1 Asia Pacific Pet Meds and Supplements Sales by Region
3.5.2 Asia Pacific Pet Meds and Supplements Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Pet Meds and Supplements Market Facts & Figures by Country
3.6.1 Latin America Pet Meds and Supplements Sales by Country
3.6.2 Latin America Pet Meds and Supplements Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Pet Meds and Supplements Market Facts & Figures by Country
3.7.1 Middle East and Africa Pet Meds and Supplements Sales by Country
3.7.2 Middle East and Africa Pet Meds and Supplements Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pet Meds and Supplements Historic Market Analysis by Type
4.1 Global Pet Meds and Supplements Sales Market Share by Type (2017-2022)
4.2 Global Pet Meds and Supplements Revenue Market Share by Type (2017-2022)
4.3 Global Pet Meds and Supplements Price by Type (2017-2022)
5 Global Pet Meds and Supplements Historic Market Analysis by Application
5.1 Global Pet Meds and Supplements Sales Market Share by Application (2017-2022)
5.2 Global Pet Meds and Supplements Revenue Market Share by Application (2017-2022)
5.3 Global Pet Meds and Supplements Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boehringer Ingelheim Pet Meds and Supplements Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Ceva Sante Animale
6.2.1 Ceva Sante Animale Corporation Information
6.2.2 Ceva Sante Animale Description and Business Overview
6.2.3 Ceva Sante Animale Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Ceva Sante Animale Pet Meds and Supplements Product Portfolio
6.2.5 Ceva Sante Animale Recent Developments/Updates
6.3 Bimeda Animal Health
6.3.1 Bimeda Animal Health Corporation Information
6.3.2 Bimeda Animal Health Description and Business Overview
6.3.3 Bimeda Animal Health Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Bimeda Animal Health Pet Meds and Supplements Product Portfolio
6.3.5 Bimeda Animal Health Recent Developments/Updates
6.4 Dechra Pharmaceuticals
6.4.1 Dechra Pharmaceuticals Corporation Information
6.4.2 Dechra Pharmaceuticals Description and Business Overview
6.4.3 Dechra Pharmaceuticals Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Dechra Pharmaceuticals Pet Meds and Supplements Product Portfolio
6.4.5 Dechra Pharmaceuticals Recent Developments/Updates
6.5 Zoetis
6.5.1 Zoetis Corporation Information
6.5.2 Zoetis Description and Business Overview
6.5.3 Zoetis Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Zoetis Pet Meds and Supplements Product Portfolio
6.5.5 Zoetis Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Merck Pet Meds and Supplements Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Elanco
6.6.1 Elanco Corporation Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Elanco Pet Meds and Supplements Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bayer Pet Meds and Supplements Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Boehringer
6.9.1 Boehringer Corporation Information
6.9.2 Boehringer Description and Business Overview
6.9.3 Boehringer Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Boehringer Pet Meds and Supplements Product Portfolio
6.9.5 Boehringer Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Novartis Pet Meds and Supplements Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Virbac
6.11.1 Virbac Corporation Information
6.11.2 Virbac Pet Meds and Supplements Description and Business Overview
6.11.3 Virbac Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Virbac Pet Meds and Supplements Product Portfolio
6.11.5 Virbac Recent Developments/Updates
6.12 Ceva
6.12.1 Ceva Corporation Information
6.12.2 Ceva Pet Meds and Supplements Description and Business Overview
6.12.3 Ceva Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Ceva Pet Meds and Supplements Product Portfolio
6.12.5 Ceva Recent Developments/Updates
6.13 Vetoquinol
6.13.1 Vetoquinol Corporation Information
6.13.2 Vetoquinol Pet Meds and Supplements Description and Business Overview
6.13.3 Vetoquinol Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Vetoquinol Pet Meds and Supplements Product Portfolio
6.13.5 Vetoquinol Recent Developments/Updates
6.14 Nexvet
6.14.1 Nexvet Corporation Information
6.14.2 Nexvet Pet Meds and Supplements Description and Business Overview
6.14.3 Nexvet Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Nexvet Pet Meds and Supplements Product Portfolio
6.14.5 Nexvet Recent Developments/Updates
6.15 Aratana Therapeutics
6.15.1 Aratana Therapeutics Corporation Information
6.15.2 Aratana Therapeutics Pet Meds and Supplements Description and Business Overview
6.15.3 Aratana Therapeutics Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Aratana Therapeutics Pet Meds and Supplements Product Portfolio
6.15.5 Aratana Therapeutics Recent Developments/Updates
6.16 Kindred Biosciences
6.16.1 Kindred Biosciences Corporation Information
6.16.2 Kindred Biosciences Pet Meds and Supplements Description and Business Overview
6.16.3 Kindred Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Kindred Biosciences Pet Meds and Supplements Product Portfolio
6.16.5 Kindred Biosciences Recent Developments/Updates
6.17 Ambrx
6.17.1 Ambrx Corporation Information
6.17.2 Ambrx Pet Meds and Supplements Description and Business Overview
6.17.3 Ambrx Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Ambrx Pet Meds and Supplements Product Portfolio
6.17.5 Ambrx Recent Developments/Updates
6.18 Entest Biomedical
6.18.1 Entest Biomedical Corporation Information
6.18.2 Entest Biomedical Pet Meds and Supplements Description and Business Overview
6.18.3 Entest Biomedical Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Entest Biomedical Pet Meds and Supplements Product Portfolio
6.18.5 Entest Biomedical Recent Developments/Updates
6.19 Taconic Biosciences
6.19.1 Taconic Biosciences Corporation Information
6.19.2 Taconic Biosciences Pet Meds and Supplements Description and Business Overview
6.19.3 Taconic Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Taconic Biosciences Pet Meds and Supplements Product Portfolio
6.19.5 Taconic Biosciences Recent Developments/Updates
6.20 Dechra Veterinary Products
6.20.1 Dechra Veterinary Products Corporation Information
6.20.2 Dechra Veterinary Products Pet Meds and Supplements Description and Business Overview
6.20.3 Dechra Veterinary Products Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Dechra Veterinary Products Pet Meds and Supplements Product Portfolio
6.20.5 Dechra Veterinary Products Recent Developments/Updates
6.21 Ouro Fino Saude
6.21.1 Ouro Fino Saude Corporation Information
6.21.2 Ouro Fino Saude Pet Meds and Supplements Description and Business Overview
6.21.3 Ouro Fino Saude Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Ouro Fino Saude Pet Meds and Supplements Product Portfolio
6.21.5 Ouro Fino Saude Recent Developments/Updates
6.22 Norbrook
6.22.1 Norbrook Corporation Information
6.22.2 Norbrook Pet Meds and Supplements Description and Business Overview
6.22.3 Norbrook Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Norbrook Pet Meds and Supplements Product Portfolio
6.22.5 Norbrook Recent Developments/Updates
6.23 Frontline
6.23.1 Frontline Corporation Information
6.23.2 Frontline Pet Meds and Supplements Description and Business Overview
6.23.3 Frontline Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Frontline Pet Meds and Supplements Product Portfolio
6.23.5 Frontline Recent Developments/Updates
6.24 Zesty Paws
6.24.1 Zesty Paws Corporation Information
6.24.2 Zesty Paws Pet Meds and Supplements Description and Business Overview
6.24.3 Zesty Paws Pet Meds and Supplements Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Zesty Paws Pet Meds and Supplements Product Portfolio
6.24.5 Zesty Paws Recent Developments/Updates
7 Pet Meds and Supplements Manufacturing Cost Analysis
7.1 Pet Meds and Supplements Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pet Meds and Supplements
7.4 Pet Meds and Supplements Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pet Meds and Supplements Distributors List
8.3 Pet Meds and Supplements Customers
9 Pet Meds and Supplements Market Dynamics
9.1 Pet Meds and Supplements Industry Trends
9.2 Pet Meds and Supplements Market Drivers
9.3 Pet Meds and Supplements Market Challenges
9.4 Pet Meds and Supplements Market Restraints
10 Global Market Forecast
10.1 Pet Meds and Supplements Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pet Meds and Supplements by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Pet Meds and Supplements by Type (2023-2028)
10.2 Pet Meds and Supplements Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pet Meds and Supplements by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Pet Meds and Supplements by Application (2023-2028)
10.3 Pet Meds and Supplements Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pet Meds and Supplements by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Pet Meds and Supplements by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Pet Meds and Supplements Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Pet Meds and Supplements Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Pet Meds and Supplements Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Pet Meds and Supplements Market Competitive Situation by Manufacturers in 2021
Table 5. Global Pet Meds and Supplements Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Pet Meds and Supplements Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Pet Meds and Supplements Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Pet Meds and Supplements Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Pet Meds and Supplements Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Pet Meds and Supplements Manufacturing Sites and Area Served
Table 11. Manufacturers Pet Meds and Supplements Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pet Meds and Supplements by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pet Meds and Supplements as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pet Meds and Supplements Sales by Region (2017-2022) & (Units)
Table 16. Global Pet Meds and Supplements Sales Market Share by Region (2017-2022)
Table 17. Global Pet Meds and Supplements Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Pet Meds and Supplements Revenue Market Share by Region (2017-2022)
Table 19. North America Pet Meds and Supplements Sales by Country (2017-2022) & (Units)
Table 20. North America Pet Meds and Supplements Sales Market Share by Country (2017-2022)
Table 21. North America Pet Meds and Supplements Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Pet Meds and Supplements Revenue Market Share by Country (2017-2022)
Table 23. Europe Pet Meds and Supplements Sales by Country (2017-2022) & (Units)
Table 24. Europe Pet Meds and Supplements Sales Market Share by Country (2017-2022)
Table 25. Europe Pet Meds and Supplements Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Pet Meds and Supplements Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Pet Meds and Supplements Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Pet Meds and Supplements Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Pet Meds and Supplements Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Pet Meds and Supplements Revenue Market Share by Region (2017-2022)
Table 31. Latin America Pet Meds and Supplements Sales by Country (2017-2022) & (Units)
Table 32. Latin America Pet Meds and Supplements Sales Market Share by Country (2017-2022)
Table 33. Latin America Pet Meds and Supplements Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Pet Meds and Supplements Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Pet Meds and Supplements Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Pet Meds and Supplements Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Pet Meds and Supplements Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Pet Meds and Supplements Revenue Market Share by Country (2017-2022)
Table 39. Global Pet Meds and Supplements Sales by Type (2017-2022) & (Units)
Table 40. Global Pet Meds and Supplements Sales Market Share by Type (2017-2022)
Table 41. Global Pet Meds and Supplements Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Pet Meds and Supplements Revenue Share by Type (2017-2022)
Table 43. Global Pet Meds and Supplements Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Pet Meds and Supplements Sales (Units) by Application (2017-2022)
Table 45. Global Pet Meds and Supplements Sales Market Share by Application (2017-2022)
Table 46. Global Pet Meds and Supplements Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Pet Meds and Supplements Revenue Share by Application (2017-2022)
Table 48. Global Pet Meds and Supplements Price by Application (2017-2022) & (US$/Unit)
Table 49. Boehringer Ingelheim Corporation Information
Table 50. Boehringer Ingelheim Description and Business Overview
Table 51. Boehringer Ingelheim Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Boehringer Ingelheim Pet Meds and Supplements Product
Table 53. Boehringer Ingelheim Recent Developments/Updates
Table 54. Ceva Sante Animale Corporation Information
Table 55. Ceva Sante Animale Description and Business Overview
Table 56. Ceva Sante Animale Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Ceva Sante Animale Pet Meds and Supplements Product
Table 58. Ceva Sante Animale Recent Developments/Updates
Table 59. Bimeda Animal Health Corporation Information
Table 60. Bimeda Animal Health Description and Business Overview
Table 61. Bimeda Animal Health Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Bimeda Animal Health Pet Meds and Supplements Product
Table 63. Bimeda Animal Health Recent Developments/Updates
Table 64. Dechra Pharmaceuticals Corporation Information
Table 65. Dechra Pharmaceuticals Description and Business Overview
Table 66. Dechra Pharmaceuticals Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Dechra Pharmaceuticals Pet Meds and Supplements Product
Table 68. Dechra Pharmaceuticals Recent Developments/Updates
Table 69. Zoetis Corporation Information
Table 70. Zoetis Description and Business Overview
Table 71. Zoetis Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Zoetis Pet Meds and Supplements Product
Table 73. Zoetis Recent Developments/Updates
Table 74. Merck Corporation Information
Table 75. Merck Description and Business Overview
Table 76. Merck Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Merck Pet Meds and Supplements Product
Table 78. Merck Recent Developments/Updates
Table 79. Elanco Corporation Information
Table 80. Elanco Description and Business Overview
Table 81. Elanco Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Elanco Pet Meds and Supplements Product
Table 83. Elanco Recent Developments/Updates
Table 84. Bayer Corporation Information
Table 85. Bayer Description and Business Overview
Table 86. Bayer Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Bayer Pet Meds and Supplements Product
Table 88. Bayer Recent Developments/Updates
Table 89. Boehringer Corporation Information
Table 90. Boehringer Description and Business Overview
Table 91. Boehringer Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Boehringer Pet Meds and Supplements Product
Table 93. Boehringer Recent Developments/Updates
Table 94. Novartis Corporation Information
Table 95. Novartis Description and Business Overview
Table 96. Novartis Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Novartis Pet Meds and Supplements Product
Table 98. Novartis Recent Developments/Updates
Table 99. Virbac Corporation Information
Table 100. Virbac Description and Business Overview
Table 101. Virbac Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Virbac Pet Meds and Supplements Product
Table 103. Virbac Recent Developments/Updates
Table 104. Ceva Corporation Information
Table 105. Ceva Description and Business Overview
Table 106. Ceva Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Ceva Pet Meds and Supplements Product
Table 108. Ceva Recent Developments/Updates
Table 109. Vetoquinol Corporation Information
Table 110. Vetoquinol Description and Business Overview
Table 111. Vetoquinol Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. Vetoquinol Pet Meds and Supplements Product
Table 113. Vetoquinol Recent Developments/Updates
Table 114. Nexvet Corporation Information
Table 115. Nexvet Description and Business Overview
Table 116. Nexvet Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Nexvet Pet Meds and Supplements Product
Table 118. Nexvet Recent Developments/Updates
Table 119. Aratana Therapeutics Corporation Information
Table 120. Aratana Therapeutics Description and Business Overview
Table 121. Aratana Therapeutics Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Aratana Therapeutics Pet Meds and Supplements Product
Table 123. Aratana Therapeutics Recent Developments/Updates
Table 124. Kindred Biosciences Corporation Information
Table 125. Kindred Biosciences Description and Business Overview
Table 126. Kindred Biosciences Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Kindred Biosciences Pet Meds and Supplements Product
Table 128. Kindred Biosciences Recent Developments/Updates
Table 129. Ambrx Corporation Information
Table 130. Ambrx Description and Business Overview
Table 131. Ambrx Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Ambrx Pet Meds and Supplements Product
Table 133. Ambrx Recent Developments/Updates
Table 134. Entest Biomedical Corporation Information
Table 135. Entest Biomedical Description and Business Overview
Table 136. Entest Biomedical Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Entest Biomedical Pet Meds and Supplements Product
Table 138. Entest Biomedical Recent Developments/Updates
Table 139. Taconic Biosciences Corporation Information
Table 140. Taconic Biosciences Description and Business Overview
Table 141. Taconic Biosciences Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. Taconic Biosciences Pet Meds and Supplements Product
Table 143. Taconic Biosciences Recent Developments/Updates
Table 144. Dechra Veterinary Products Corporation Information
Table 145. Dechra Veterinary Products Description and Business Overview
Table 146. Dechra Veterinary Products Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 147. Dechra Veterinary Products Pet Meds and Supplements Product
Table 148. Dechra Veterinary Products Recent Developments/Updates
Table 149. Ouro Fino Saude Corporation Information
Table 150. Ouro Fino Saude Description and Business Overview
Table 151. Ouro Fino Saude Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 152. Ouro Fino Saude Pet Meds and Supplements Product
Table 153. Ouro Fino Saude Recent Developments/Updates
Table 154. Norbrook Corporation Information
Table 155. Norbrook Description and Business Overview
Table 156. Norbrook Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 157. Norbrook Pet Meds and Supplements Product
Table 158. Norbrook Recent Developments/Updates
Table 159. Frontline Corporation Information
Table 160. Frontline Description and Business Overview
Table 161. Frontline Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 162. Frontline Pet Meds and Supplements Product
Table 163. Frontline Recent Developments/Updates
Table 164. Zesty Paws Corporation Information
Table 165. Zesty Paws Description and Business Overview
Table 166. Zesty Paws Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 167. Zesty Paws Pet Meds and Supplements Product
Table 168. Zesty Paws Recent Developments/Updates
Table 169. Production Base and Market Concentration Rate of Raw Material
Table 170. Key Suppliers of Raw Materials
Table 171. Pet Meds and Supplements Distributors List
Table 172. Pet Meds and Supplements Customers List
Table 173. Pet Meds and Supplements Market Trends
Table 174. Pet Meds and Supplements Market Drivers
Table 175. Pet Meds and Supplements Market Challenges
Table 176. Pet Meds and Supplements Market Restraints
Table 177. Global Pet Meds and Supplements Sales Forecast by Type (2023-2028) & (Units)
Table 178. Global Pet Meds and Supplements Sales Market Share Forecast by Type (2023-2028)
Table 179. Global Pet Meds and Supplements Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 180. Global Pet Meds and Supplements Revenue Market Share Forecast by Type (2023-2028)
Table 181. Global Pet Meds and Supplements Sales Forecast by Application (2023-2028) & (Units)
Table 182. Global Pet Meds and Supplements Sales Market Share Forecast by Application (2023-2028)
Table 183. Global Pet Meds and Supplements Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 184. Global Pet Meds and Supplements Revenue Market Share Forecast by Application (2023-2028)
Table 185. Global Pet Meds and Supplements Sales Forecast by Region (2023-2028) & (Units)
Table 186. Global Pet Meds and Supplements Sales Market Share Forecast by Region (2023-2028)
Table 187. Global Pet Meds and Supplements Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 188. Global Pet Meds and Supplements Revenue Market Share Forecast by Region (2023-2028)
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet Meds and Supplements
Figure 2. Global Pet Meds and Supplements Market Share by Type in 2021 & 2028
Figure 3. External Use Product Picture
Figure 4. Oral Use Product Picture
Figure 5. Global Pet Meds and Supplements Market Share by Application in 2021 & 2028
Figure 6. Dogs
Figure 7. Cats
Figure 8. Rabbit
Figure 9. Bird
Figure 10. Other
Figure 11. Global Pet Meds and Supplements Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Pet Meds and Supplements Market Size (2017-2028) & (US$ Million)
Figure 13. Global Pet Meds and Supplements Sales (2017-2028) & (Units)
Figure 14. Pet Meds and Supplements Sales Share by Manufacturers in 2021
Figure 15. Global Pet Meds and Supplements Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Pet Meds and Supplements Players: Market Share by Revenue in 2021
Figure 17. Pet Meds and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Pet Meds and Supplements Sales Market Share by Region (2017-2022)
Figure 19. Global Pet Meds and Supplements Sales Market Share by Region in 2021
Figure 20. Global Pet Meds and Supplements Revenue Market Share by Region (2017-2022)
Figure 21. Global Pet Meds and Supplements Revenue Market Share by Region in 2021
Figure 22. United States Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Colombia Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Turkey Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Saudi Arabia Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. UAE Pet Meds and Supplements Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Sales Market Share of Pet Meds and Supplements by Type (2017-2022)
Figure 46. Manufacturing Cost Structure of Pet Meds and Supplements
Figure 47. Manufacturing Process Analysis of Pet Meds and Supplements
Figure 48. Pet Meds and Supplements Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed